These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 26301065

  • 1. Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementation.
    Tucci JR, Bone HG, Su G, Tan M, Ozturk ZE, Aftring P.
    Ther Adv Endocrinol Metab; 2015 Aug; 6(4):155-62. PubMed ID: 26301065
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.
    Ferraz-de-Souza B, Martin RM, Correa PH.
    J Bone Miner Metab; 2013 May; 31(3):360-5. PubMed ID: 23076294
    [Abstract] [Full Text] [Related]

  • 3. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 4. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA, Anastasilakis AD, Makras P, Terpos E.
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
    [Abstract] [Full Text] [Related]

  • 5. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Dec; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 8. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 9. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
    Tanvetyanon T, Choudhury AM.
    Ann Pharmacother; 2004 Mar 01; 38(3):418-21. PubMed ID: 14970365
    [Abstract] [Full Text] [Related]

  • 18. Paget's disease of bone: emphasis on treatment with zoledronic acid.
    Polyzos SA, Anastasilakis AD, Terpos E.
    Expert Rev Endocrinol Metab; 2009 Sep 01; 4(5):423-434. PubMed ID: 30736184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.